Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Possibly Marketed Outside US

10

US Approved Rx

10

US Previously Marketed

2

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Beta-1 adrenergic receptor

15

Beta-2 adrenergic receptor

9

Adrenergic receptor beta

6

Serotonin 1a (5-HT1a) receptor

2

Adenylate Cyclase (guinea pig)

1

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

17

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

Unknown

10

1967

1

1978

1

1982

1

1983

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Hypertension

12

Angina pectoris

3

Myocardial infarction

3

Ocular hypertension

3

Open-angle glaucoma

3

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

18

Preventing

2

Palliative

1

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Non-penetrant

6

CNS Active

5

CNS Penetrant

5

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Sandoz

2

Bausch and Lomb Pharmaceuticals

1

Black, J.W.

1

Boehringer Mannheim

1

Chemie Linz

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

22

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

22

ChEMBL

22

DRUG CENTRAL

22

EPA CompTox

22

EVMPD

22

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

CARDIOVASCULAR SYSTEM

21

SENSORY ORGANS

4

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

BETA BLOCKING AGENTS

21

OPHTHALMOLOGICALS

4

AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM

2

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

BETA BLOCKING AGENTS

20

BETA BLOCKING AGENTS AND THIAZIDES

8

ANTIGLAUCOMA PREPARATIONS AND MIOTICS

4

BETA BLOCKING AGENTS, OTHER COMBINATIONS

4

BETA BLOCKING AGENTS AND OTHER DIURETICS

3

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Beta blocking agents, selective

11

Beta blocking agents, non-selective

8

Beta blocking agents

4

Beta blocking agents, non-selective, and thiazides

4

Beta blocking agents, selective, and thiazides

4

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

20

Salts, Hydrates, Esters, etc.

2

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "VATC|BETA BLOCKING AGENTS" in comments (approximate match)

Showing 1 - 10 of 22 results

First page disabled
Previous page disabled
1
Next page
Next page

NEBIVOLOL

030Y90569U

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

CARVEDILOL

0K47UL67F2

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

BISOPROLOL

Y41JS2NL6U

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

CARTEOLOL

8NF31401XG

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

ESMOLOL

MDY902UXSR

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

BETAXOLOL

O0ZR1R6RZ2

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

ACEBUTOLOL

67P356D8GH

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

PINDOLOL

BJ4HF6IU1D

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

PROPRANOLOL

9Y8NXQ24VQ

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

OXPRENOLOL

519MXN9YZR

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

Showing 1 - 10 of 22 results

First page disabled
Previous page disabled
1
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1